Phosphatase inhibitor 2 promotes acetylation of tubulin in the primary cilium of human retinal epithelial cells
2008

Phosphatase Inhibitor 2 and Tubulin Acetylation in Primary Cilia

Sample size: 200 publication 10 minutes Evidence: moderate

Author Information

Author(s): Wang Weiping, Brautigan David L

Primary Institution: University of Virginia, School of Medicine

Hypothesis

How does phosphatase inhibitor 2 (I-2) affect tubulin acetylation in the primary cilium of human retinal epithelial cells?

Conclusion

Phosphatase inhibitor 2 (I-2) is essential for the full acetylation of tubulin in the primary cilium, and its knockdown reduces both the acetylation and the percentage of cells with a primary cilium.

Supporting Evidence

  • Knockdown of I-2 reduced the percentage of cells with a primary cilium from 65% to 40%.
  • Chemical inhibitors of HDACs or PP1 partially rescued the effects of I-2 knockdown.
  • I-2 was found concentrated in the primary cilium before tubulin acetylation occurred.
  • Immunoblotting confirmed the presence of I-2 and acetylated tubulin in the cilia fraction.
  • Acetylation stabilizes microtubules, which are crucial for ciliary function.

Takeaway

I-2 helps make a part of the cell called the primary cilium strong and stable by adding a special tag to its building blocks, called tubulin. If I-2 is missing, the cilium doesn't work as well.

Methodology

The study involved siRNA knockdown of I-2 in ARPE-19 cells, followed by immunoblotting and immunofluorescent staining to assess tubulin acetylation and primary cilium formation.

Potential Biases

Potential bias in the interpretation of immunostaining results and reliance on specific siRNA targeting.

Limitations

The study primarily focused on a single cell line (ARPE-19) and may not generalize to other cell types.

Participant Demographics

Human retinal epithelial cells (ARPE-19).

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2121-9-62

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication